- Drug Pipelines
- April 2024
- 80 Pages
Global
From €1901EUR$2,000USD£1,597GBP
- Report
- June 2024
- 200 Pages
Global
From €7558EUR$7,950USD£6,349GBP
- Report
- June 2024
- 200 Pages
Global
From €7558EUR$7,950USD£6,349GBP
- Clinical Trials
- April 2024
- 60 Pages
Global
From €1901EUR$2,000USD£1,597GBP
- Clinical Trials
- April 2024
- 60 Pages
Global
From €1901EUR$2,000USD£1,597GBP
- Report
- May 2024
- 129 Pages
Global
From €6178EUR$6,499USD£5,190GBP
- Report
- January 2025
- 250 Pages
Global
From €4752EUR$4,999USD£3,992GBP
- Report
- January 2024
- 129 Pages
United States
From €3565EUR$3,750USD£2,995GBP
- Report
- January 2024
- 216 Pages
United States
From €3565EUR$3,750USD£2,995GBP
- Drug Pipelines
- November 2023
- 30 Pages
United States
From €2614EUR$2,750USD£2,196GBP
- Drug Pipelines
- November 2023
- 30 Pages
United States
From €2614EUR$2,750USD£2,196GBP
- Drug Pipelines
- November 2023
- 30 Pages
United States
From €2614EUR$2,750USD£2,196GBP
- Report
- January 2022
- 200 Pages
Global
From €7130EUR$7,500USD£5,990GBP
- Report
- January 2022
- 60 Pages
Global
From €3755EUR$3,950USD£3,155GBP
- Drug Pipelines
- November 2023
- 30 Pages
United States
From €2614EUR$2,750USD£2,196GBP
- Report
- March 2022
- 324 Pages
Global
From €9031EUR$9,500USD£7,587GBP
- Drug Pipelines
- March 2022
- 162 Pages
Global
From €5419EUR$5,700USD£4,552GBP
- Report
- January 2022
- 60 Pages
Global
From €3755EUR$3,950USD£3,155GBP
- Report
- January 2022
- 60 Pages
Global
From €3755EUR$3,950USD£3,155GBP
- Report
- August 2022
United States
From €1844EUR$1,940USD£1,549GBP

Analgesics are a class of drugs used to treat pain. Acute pain medicine is a subset of analgesics used to treat short-term, severe pain. Acute pain medicine is typically used to treat pain caused by injury, surgery, or other medical conditions. Common acute pain medicines include non-steroidal anti-inflammatory drugs (NSAIDs), opioids, and acetaminophen. NSAIDs are used to reduce inflammation and pain, while opioids are used to treat more severe pain. Acute pain medicines are available in both prescription and over-the-counter forms.
Acute pain medicine is a large and growing market. It is estimated that the global market for acute pain medicine will reach $50 billion by 2025. The market is driven by an aging population, increasing prevalence of chronic pain, and the development of new drugs.
Some companies in the acute pain medicine market include Pfizer, Johnson & Johnson, Merck, Novartis, and GlaxoSmithKline. Show Less Read more